Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Epstein-Barr virus (EBV)–associated tumors developing in immunocompetent individuals present a challenge to immunotherapy, since they lack expression of immunodominant viral antigens. However, the tumors consistently express viral proteins including LMP2, which are immunologically “weak” but may non...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bollard, Catherine M., Gottschalk, Stephen, Leen, Ann M., Weiss, Heidi, Straathof, Karin C., Carrum, George, Khalil, Mariam, Wu, Meng-fen, Huls, M. Helen, Chang, Chung-Che, Gresik, M. Victoria, Gee, Adrian P., Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2007
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2018666/
https://ncbi.nlm.nih.gov/pubmed/17609424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-05-091280
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller